Cartagenia Raises $2.9M in Private Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cartagenia, a Leuven, Belgium-based firm developing software and database systems for genetic analyses, today said that it has received a capital injection of €2.2 million ($2.9 million).

The company said that it would use the funds to further develop its market presence, open an office in the US, and invest in a new product line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.